Clinical Trials Directory

Trials / Conditions / Paraproteinemias

Paraproteinemias

14 registered clinical trials studyying Paraproteinemias — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT07075185
Kelonia Therapeutics, Inc.Phase 1
RecruitingA Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
NCT06271252
OriCell Therapeutics Co., Ltd.Phase 1
RecruitingThe Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
NCT06889948
Helsinki University Central HospitalPhase 2
RecruitingA Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide,
NCT05573802
Hellenic Society of HematologyPhase 1 / Phase 2
Not Yet RecruitingA Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma
NCT05581875
Hellenic Society of HematologyPhase 1 / Phase 2
UnknownA Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received O
NCT05298683
Hellenic Society of HematologyPhase 2
UnknownA Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma
NCT05280275
Hellenic Society of HematologyPhase 1 / Phase 2
UnknownA Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by I
NCT05147493
Hellenic Society of HematologyPhase 2
UnknownNatural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
NCT04309084
Celularity IncorporatedPhase 1
WithdrawnContinuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or T
NCT02155634
CelgenePhase 3
CompletedComprehensive Frailty Assessment
NCT02033928
Ohio State University Comprehensive Cancer Center—
WithdrawnProspective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
NCT02462213
University of Cincinnati—
CompletedStudy of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
NCT01755000
Washington University School of MedicineN/A
CompletedIntravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP
NCT00001287
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2